Study Shows Smaller Thalamus in Schizophrenia Patients

Article

LONDON-A British psychiatrist has discovered that the brain's main sensory filter is smaller in people suffering from schizophrenia.

Dr. Tonmoy Sharma of the Institute of Psychiatry used magnetic resonance imaging on 67 people. His findings showed that 38 people in the group who had suffered their first psychosis had a smaller thalamus. The other volunteers were healthy and had normal thalamus size and function.

The thalamus translates neural impulses from various receptors to the cerebral cortex and regulates synaptic transmissions during resting states.

Schizophrenia affects 1 in 100 people worldwide and affects men and women with equal frequency. The neurological disorder is caused by a neurochemical imbalance. Symptoms include delusions, hallucinations, disorganizes speech, and grossly disorganized or catatonic behavior.

The disease is not characterized by "split personalities" as commonly believed. It is a brain disease caused by biochemical changes.

Information from www.houstonchronicle.com, www.surgeongeneral.gov, www.mhsource.com,www.mentalhealth.com

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.